Petal Bio
PrivateSF-based biotech engineering AI-designed enzyme therapeutics for lysosomal storage disorders.
Company
Founded
2023
Headquarters
San Francisco, United States
Financials
Total Funding
$51M
Sectors
Funding History
2 rounds Series A Aug 24, 2026
$40M Seed Mar 5, 2024
$11M Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.